Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis
- PMID: 31014268
- PMCID: PMC6480723
- DOI: 10.1186/s12885-019-5585-5
Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis
Abstract
Background: As the efficacy of radiotherapy and chemotherapy for treatment of phyllodes tumors (PTs) remains unclear, this study aimed to review all available data and evaluate the roles of radiotherapy and chemotherapy in PT treatment.
Methods: We performed a comprehensive search of databases, including PubMed, Web of Science and the Cochrane Library. The outcomes of interest included the local recurrence (LR) rate, metastasis rate, disease-free survival rate and overall survival rate.
Results: Seventeen studies enrolling 696 patients were included in this random effect meta-analysis. Subgroup analysis and meta-regression were also conducted to determine study heterogeneity. A pooled local recurrence rate of 8% (95% CI: 1-22%) was observed with a statistical heterogeneity of I2 = 86.6% (p < 0.01) for radiotherapy. This was lower than the recurrence rate of 12% for simple surgical treatment (95% CI: 7-18%). Meta-regression analysis found that surgical margin status was the main source of heterogeneity (p = 0.04). The metastasis rate of 4% (95% CI: 0-11%) for patients receiving radiotherapy without significant heterogeneity was also lower than the rate for the simple surgery group (8, 95% CI: 3-15%). The available data for chemotherapy were too limited to support meta-analysis. Accordingly, we offer a pure review of these data.
Conclusion: Our findings suggest that radiotherapy is effective in achieving local disease control and preventing metastasis.
Keywords: Chemotherapy; Meta-analysis; Phyllodes tumors; Radiotherapy.
Conflict of interest statement
Ethics approval and consent to participate
This study involved the use of existing collections of data or records that contain only non-identifiable data. Thus, ethics approval is not needed. Written, informed consent was provided by all participants in each of the studies included in this individual patient meta-analysis.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.Cancer Radiother. 2018 Apr;22(2):112-119. doi: 10.1016/j.canrad.2017.08.112. Epub 2018 Mar 7. Cancer Radiother. 2018. PMID: 29523388
-
Malignant phyllodes tumor of the breast: treatment and prognosis.Breast J. 2014 Nov-Dec;20(6):639-44. doi: 10.1111/tbj.12333. Epub 2014 Sep 17. Breast J. 2014. PMID: 25227987
-
[Analysis of the treatment and prognosis of recurrent breast phyllodes tumor].Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):72-4. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538877 Chinese.
-
Phyllodes tumors of the breast: A comprehensive review of diagnosis, treatment, and follow-up.Clinics (Sao Paulo). 2025 Mar 14;80:100617. doi: 10.1016/j.clinsp.2025.100617. eCollection 2025. Clinics (Sao Paulo). 2025. PMID: 40088524 Free PMC article. Review.
-
Management of non metastatic phyllodes tumors of the breast: review of the literature.Surg Oncol. 2011 Dec;20(4):e143-8. doi: 10.1016/j.suronc.2011.04.007. Epub 2011 May 24. Surg Oncol. 2011. PMID: 21609854 Review.
Cited by
-
Multifocal intra-parenchymal and sub-pectoral malignant phyllodes tumor in young female, rare and unusual presentation: A case report.Int J Surg Case Rep. 2020;71:280-284. doi: 10.1016/j.ijscr.2020.05.014. Epub 2020 May 22. Int J Surg Case Rep. 2020. PMID: 32480338 Free PMC article.
-
Malignant Phyllodes Tumor in an Adolescent Female: A Rare Case Report and Review of the Literature.Case Rep Oncol Med. 2020 Feb 28;2020:1989452. doi: 10.1155/2020/1989452. eCollection 2020. Case Rep Oncol Med. 2020. PMID: 32181035 Free PMC article.
-
Malignant Phyllodes Tumor: Report of Two Cases and Review of Literature.Niger Med J. 2022 May 28;62(6):371-376. doi: 10.60787/NMJ-62-6-70. eCollection 2021 Nov-Dec. Niger Med J. 2022. PMID: 38736519 Free PMC article.
-
Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.Adv Radiat Oncol. 2024 Jan 26;9(5):101448. doi: 10.1016/j.adro.2024.101448. eCollection 2024 May. Adv Radiat Oncol. 2024. PMID: 38550370 Free PMC article. No abstract available.
-
A case report of a patient with ductal carcinoma and a malignant phyllodes tumor in situ in 2 separate breasts.Medicine (Baltimore). 2023 Dec 1;102(48):e36405. doi: 10.1097/MD.0000000000036405. Medicine (Baltimore). 2023. PMID: 38050272 Free PMC article.
References
-
- Histological typing of breast tumors. Tumori. 1982;68(3):181–98. PMID:6291202, https://www.ncbi.nlm.nih.gov/pubmed/6291202. - PubMed
-
- Lakhani SREIO, Schnitt SJ, Tan PH, van de Vijver MJ. World Health Organization Classification of Tumours of the Breast, vol. 4. Lyon: World Health Organization Classification of Tumours; 2012.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials